- Allergic Rhinitis and Sensitization
- Food Allergy and Anaphylaxis Research
- Asthma and respiratory diseases
- Protease and Inhibitor Mechanisms
- Complementary and Alternative Medicine Studies
- Cardiac Fibrosis and Remodeling
- Patient-Provider Communication in Healthcare
- Urticaria and Related Conditions
- Signaling Pathways in Disease
- Drug-Induced Adverse Reactions
- IL-33, ST2, and ILC Pathways
- Eosinophilic Esophagitis
- Ethics in Clinical Research
Stanford University
2020
University of Pennsylvania
2014-2020
Temple University
2017
The pore-forming protein perforin-2 facilitates IL-33 release from dendritic cells.
As breast cancer patients increasingly use complementary and alternative medicine (CAM), clinical trials are needed to guide appropriate use. We sought identify socio-demographic, psychological factors related willingness participate (WTP) determine barriers participation in an acupuncture trial among patients.We conducted a cross-sectional survey study post-menopausal women with stage I-III on aromatase inhibitors at urban academic center.Of the 300 participants (92% response rate), 148...
Therapy with adjunct omalizumab in multiple food allergen oral immunotherapy (mOIT) is associated faster desensitization and increased tolerability; however, the minimum maintenance dose of each protein mOIT required to achieve successful clinical outcomes not yet known.
Several clinical trials have shown that adjunct therapy with omalizumab multiallergen food oral immunotherapy (mOIT) is safe and effective; however, optimal dosing strategies in the setting of mOIT not been explored.
Abstract Chronic obstructive pulmonary disease (COPD) is an incurable, progressive lung characterized by shortness and difficulty in breathing. Patients with COPD are at higher risk of developing cancer often associated poor outcome diagnosis treatment. Extracellular matrix (ECM) remodeling degradation one the common hallmarks between COPD. It contributes to air sacs (emphysema) or small airways (obstructive bronchiolitis). also involved initiation progression assist tumor expansion cell...